<DOC>
	<DOCNO>NCT00885612</DOCNO>
	<brief_summary>10-year CHD risk evaluation treatment pattern analysis postmenopausal early breast cancer patient take aromatase inhibitor .</brief_summary>
	<brief_title>10 Year Coronary Heart Disease ( CHD ) Risk Evaluation Its Treatment Pattern Analysis Postmenopausal Early Breast Cancer ( EBC ) Patients Taking Aromatase Inhibitors ( AI )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Early Breast Cancer patient Postmenopausal Status patient take Aromatase Inhibitor adjuvant treatment longer 6 month Advanced Breast Cancer patient ( stage iii , iv ) Patients hard analysed limitation chart record accord investigator discretion patient already register study</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>CHD-Risk</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Aromatase Inhibitors</keyword>
	<keyword>postmenopausal early breast cancer</keyword>
</DOC>